Genetic Approaches to the Investigation of the Mechanisms of Hematopoietic Progenitor Cell Mobilization into the Blood

  • Andrew W. Roberts
  • Simon Foote
  • Donald Metcalf


Despite an enormous body of knowledge regarding hematopoietic cell growth and differentiation and the regulation of these processes by hematopoietic growth factors, the phenomenon of progenitor cell mobilization remains an enigma. With the expectation that clinical development of blood stem cell transplantation will be greatly benefited by advances in knowledge about the specific processes which underpin mobilization, we have sought to define the limiting steps which regulate blood progenitor cell numbers following in vivo stimulation with G-CSF. This paper reviews the rationale behind the genetic approach we have chosen to take and summarises our recent promising, but preliminary, results.


Quantitative Trait Locus Progenitor Cell Recombinant Inbred Peripheral Blood Progenitor Cell Stem Cell Phenotype 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aiuti A, Webb IJ, Bleui C, Springer T, Gutierrez-Ramos JC: The chemokine SDF-1 is a chemoattrac-tant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185: 111, 1997.PubMedCrossRefGoogle Scholar
  2. 2.
    Laterveer L, Lindley IJD, Hamilton MS, Willemze R, Fibbe WE: Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 85: 2269, 1995.PubMedGoogle Scholar
  3. 3.
    Liu F, Poursine-Laurent J, Link DC: The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand. Blood 90: 2522, 1997.PubMedGoogle Scholar
  4. 4.
    Papayannopoulou T and Nakamoto B: Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA 90: 9374, 1993.PubMedCrossRefGoogle Scholar
  5. 5.
    Papayannopoulou T, Priestley G, Nakamoto B: Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through kit/mkit ligand pathway. Blood 91: 2231, 1998.PubMedGoogle Scholar
  6. 6.
    Roberts AW, Foote S, Alexander WS, Scott C, Robb L, Metcalf D: Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 89: 2736, 1997.PubMedGoogle Scholar
  7. 7.
    Simmons PJ, Leavesley DI, Levesque J-P, Swart BW, Haylock DN, To LB, Ashman LK, and Juttner CA: The mobilization of primitive hemopoietic progenitors into the peripheral blood. Stem Cells 12 (Suppl 1): 187, 1994.PubMedGoogle Scholar
  8. 8.
    Lander ES and Schork NJ: Genetic dissection of complex traits. Science 265: 2037, 1994.PubMedCrossRefGoogle Scholar
  9. 9.
    Lander ES and Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genetics 11: 241, 1995.PubMedCrossRefGoogle Scholar
  10. 10.
    Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D: Optimising dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86: 4437, 1995.PubMedGoogle Scholar
  11. 11.
    Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Brit J Haematol 87: 609, 1994.CrossRefGoogle Scholar
  12. 12.
    Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hard-wick A, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 85: 275, 1995.PubMedGoogle Scholar
  13. 13.
    Tjønnfjord GE, Steen R, Evensen SA, Thorsby E, Egeland T: Characterization of CD34+ peripheral blood cells from health adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 84: 2795, 1994.PubMedGoogle Scholar
  14. 14.
    Roberts AW, DeLuca E, Begley CG, Basser R, Grigg AP, Metcalf D: Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 13: 512, 1995.PubMedCrossRefGoogle Scholar
  15. 15.
    Roberts AW, Hasegawa M, Metcalf D, Foote S: Genetic influences determining in vivo responses to granulocyte colony-stimulating factor, (submitted).Google Scholar
  16. 16.
    Muller-Sieburg CE and Riblet R: Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1. J Exp Med 183: 1141, 1996.PubMedCrossRefGoogle Scholar
  17. 17.
    de Haan G and van Zant G: Intrinsic and extrinsic control of hemopoietic stem cell numbers: mapping of a stem cell gene. J Exp Med 186: 529, 1997.PubMedCrossRefGoogle Scholar
  18. 18.
    Phillips RL, Reinhart AJ, van Zant G: Genetic control of murine hematopoietic stem cell pool sizes and cycling kinetics. Proc Natl Acad Sci USA 89: 11607, 1992.PubMedCrossRefGoogle Scholar
  19. 19.
    van Zant G, Eldridge PW, Behringer RR, Dewey MJ: Genetic control of hematopoietic kinetics revealed by analyses of allophenic mice and stem cell suicide. Cell 35: 639, 1983.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Andrew W. Roberts
    • 1
    • 3
  • Simon Foote
    • 2
  • Donald Metcalf
    • 1
  1. 1.Division of Cancer and Haematology The Walter and Eliza Hall Institute of Medical Research Post OfficeRoyal Melbourne HospitalVictoriaAustralia
  2. 2.Genetics & Bioinformatics Group The Walter and Eliza Hall Institute of Medical Research Post OfficeRoyal Melbourne HospitalVictoriaAustralia
  3. 3.Division of Cancer and Genetics & Bioinformatics Group The Walter and Eliza Hall Institute of Medical Research Post OfficeRoyal Melbourne HospitalVictoriaAustralia

Personalised recommendations